{
  "created_at": "Mon Jan 31 20:15:9 +0000 2022",
  "id_str": "1488201179653971970",
  "full_text": "America’s Food and Drug Administration—hardly a cheerleader for illegal drugs—called psilocybin a “breakthrough therapy” for depression https://t.co/uAsy0fvz6W",
  "display_text_range": [
    0,
    159
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/uAsy0fvz6W",
        "expanded_url": "https://econ.st/3L4ted1",
        "display_url": "econ.st/3L4ted1",
        "indices": [
          136,
          159
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 32,
  "favorite_count": 87,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jan 31 17:23:05 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "アメリカの食品医薬品局（違法薬物の応援団ではない）は、シロシビンをうつ病の「画期的な治療法」と呼んだ https://t.co/uAsy0fvz6W"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局--很难说是非法药物的拉拉队--称迷幻药是治疗抑郁症的 \"突破性疗法 \"https://t.co/uAsy0fvz6W。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局--很難說是非法藥物的拉拉隊--稱迷幻藥是治療抑鬱症的 \"突破性療法 \"https://t.co/uAsy0fvz6W。"
    }
  ]
}